Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova posts quarterly profit

BENGALURU, Feb 2 (Reuters) - Indian pharmaceutical firm
Jubilant Pharmova  JUBA.NS  on Friday reported a third-quarter
profit, compared to a loss a year earlier, on strong demand for
its radiopharma business.
    The company posted a net profit of 668 million rupees ($8.06
million) for the quarter ended Dec. 31, compared to a loss of
156 million rupees a year ago. 
    The Noida-based firm's total revenue rose 8% to 16.77
billion rupees, with its radiopharma business - which involves
developing radioactive medications used to diagnose or treat
cancer - making up more than 40% of the total. The segment grew
22.7% during the quarter. 
    This is the fifth straight quarter that the company's
revenue has risen.    
    Jubilant Pharmova is involved in the manufacturing and
supply of radiopharmaceuticals with a network of 46
radio-pharmacies in the U.S.     
    The company's future revenue will be driven by its
high-margin radiopharmaceuticals division, according to
analysts.
    Shares of Jubilant Pharmova rose as much as 7% after the
results, hitting a more than two-year high.
     

($1 = 82.8630 Indian rupees)

 (Reporting by Ashish Chandra in Bengaluru; Editing by Sonia
Cheema)
 ((ashish.chandra@thomsonreuters.com; +91 7982114624;))

Recent news on Jubilant Pharmova

See all news